These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 9315414

  • 21. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY, Plu-Bureau G, Zitoun D, Bara L, Guize L, Samama MM.
    Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
    [Abstract] [Full Text] [Related]

  • 22. Hemostatic and metabolic effects of lowering the ethinyl-estradiol dose from 30 mcg to 20 mcg in oral contraceptives containing desogestrel.
    Basdevant A, Conard J, Pelissier C, Guyene TT, Lapousterle C, Mayer M, Guy-Grand B, Degrelle H.
    Contraception; 1993 Sep; 48(3):193-204. PubMed ID: 8222650
    [Abstract] [Full Text] [Related]

  • 23. [Hemostatic balance during treatment with the newest contraceptives].
    Petersen KR, Skouby SO, Sidelmann J, Jespersen J.
    Ugeskr Laeger; 1994 Jan 10; 156(2):187-90. PubMed ID: 8296409
    [Abstract] [Full Text] [Related]

  • 24. [Blood coagulation and fibrinolysis in women receiving estrogen, gestagen and estrogen-gestagen-contraceptives (author's transl)].
    Lechner K, Hartmann E, Schneider WH, Spona J, Matt K.
    Klin Wochenschr; 1976 May 01; 54(9):431-8. PubMed ID: 1271696
    [Abstract] [Full Text] [Related]

  • 25. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
    Akerlund M, Røde A, Westergaard J.
    Br J Obstet Gynaecol; 1993 Sep 01; 100(9):832-8. PubMed ID: 8218004
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroid.
    Jespersen J, Petersen KR, Skouby SO.
    Am J Obstet Gynecol; 1990 Jul 01; 163(1 Pt 2):396-403. PubMed ID: 2196812
    [Abstract] [Full Text] [Related]

  • 28. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity.
    Rossmanith WG, Steffens D, Schramm G.
    Contraception; 1997 Jul 01; 56(1):23-30. PubMed ID: 9306028
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effects of oral contraceptives on blood coagulation. A review.
    Beller FK, Ebert C.
    Obstet Gynecol Surv; 1985 Jul 01; 40(7):425-36. PubMed ID: 3895067
    [Abstract] [Full Text] [Related]

  • 31. Effects of low and high dose oral contraceptives on blood coagulation and thrombogenesis induced by vascular subendothelium exposed to flowing human blood.
    Inauen W, Stocker G, Haeberli A, Straub PW.
    Contraception; 1991 May 01; 43(5):435-46. PubMed ID: 1833126
    [Abstract] [Full Text] [Related]

  • 32. Enhanced generation and resolution of fibrin in women above the age of 30 years using oral contraceptives low in estrogen.
    Gram J, Munkvad S, Jespersen J.
    Am J Obstet Gynecol; 1990 Jul 01; 163(1 Pt 2):438-42. PubMed ID: 2372037
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. An investigation into the effect of tenidap sodium on the pharmacokinetics of a combined oral contraceptive.
    Coates PE, Mesure R.
    Br J Clin Pharmacol; 1995 Jul 01; 39 Suppl 1(Suppl 1):47S-50S. PubMed ID: 7547095
    [Abstract] [Full Text] [Related]

  • 36. An epidemiological study of the haemostatic and other effects of oral contraceptives.
    Meade TW, Brozović M, Chakrabarth R, Howarth DJ, North WR, Stirling Y.
    Br J Haematol; 1976 Nov 01; 34(3):353-64. PubMed ID: 990177
    [Abstract] [Full Text] [Related]

  • 37. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris.
    Lucky AW, Henderson TA, Olson WH, Robisch DM, Lebwohl M, Swinyer LJ.
    J Am Acad Dermatol; 1997 Nov 01; 37(5 Pt 1):746-54. PubMed ID: 9366821
    [Abstract] [Full Text] [Related]

  • 38. Comparative studies of 30 micrograms ethinyl estradiol combined with gestodene and desogestrel on blood coagulation, fibrinolysis, and platelets.
    Daly L, Bonnar J.
    Am J Obstet Gynecol; 1990 Jul 01; 163(1 Pt 2):430-7. PubMed ID: 2142580
    [Abstract] [Full Text] [Related]

  • 39. Contraception in older woman.
    Volpe A, Silferi M, Genazzani AD, Genazzani AR.
    Contraception; 1993 Mar 01; 47(3):229-39. PubMed ID: 8462314
    [Abstract] [Full Text] [Related]

  • 40. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P, Loner U, Kapiotis S, Handler S, Schneider B, Huber J, Speiser W.
    Thromb Haemost; 1996 Nov 01; 76(5):729-34. PubMed ID: 8950781
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.